Local Institution

Memphis, Tennessee 38120

0 studies enrolling now · 19 studies all time

What they study most

Bipolar Disorder, Breast Cancer, Cancer, Diabetes Mellitus, Diabetes Mellitus II, Diabetes Mellitus, Type 2, Diabetes, Type 2, Major Depressive Disorder, Metabolics Diabetes Nos, Multiple Myeloma, Schizophrenia, Thrombosis

Studies at this site

• A Study of Adjunctive Aripiprazole in Participants With Major Depressive Disorder — Completed
• Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE) — Running, not enrolling
• Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer — Completed
• Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes" — Completed
• A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus — Completed
• Study of Aripiprazole in Patients With a History of Bipolar Disorder — Completed
• Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode — Completed
• A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder — Completed
• Study of Aripiprazole in Patients With Bipolar I Disorder — Completed
• Aripiprazole Open-Label, Safety and Tolerability Study — Completed
• Aripiprazole in Adolescents With Schizophrenia — Completed
• Aripiprazole in Children and Adolescents With Bipolar I Disorder — Completed
• A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control — Completed
• PPAR - Combination With Metformin — Completed
• Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone — Completed
• Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes — Completed
• PPAR-COMBO With Sulfonylurea — Completed
• A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics — Completed
• Dose Ranging Study With LT, Monotherapy, PPAR — Completed